- Home
- FDMT vs SPFI Comparison
FDMT vs SPFI Comparison
Compare FDMT & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | SPFI |
|---|---|---|
| Founded | 2013 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 812.0M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FDMT | SPFI |
|---|---|---|
| Price | $13.38 | $42.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $28.09 | ★ $50.50 |
| AVG Volume (30 Days) | ★ 942.7K | 97.1K |
| Earning Date | 11-09-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ 18.79 | 17.81 |
| EPS | N/A | ★ 1.82 |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | $17.77 |
| Revenue Next Year | $55.65 | $8.74 |
| P/E Ratio | ★ N/A | $23.52 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $6.96 | $35.34 |
| 52 Week High | $16.93 | $46.94 |
Technical Indicators
Market Signals| Indicator | FDMT | SPFI |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 41.10 |
| Support Level | $13.39 | $41.05 |
| Resistance Level | $14.00 | $42.58 |
| Average True Range (ATR) | 0.92 | 0.86 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 32.85 | 44.47 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.